multipl
sclerosi
ms
extens
long
last
search
virus
pathogen
hitherto
fail
identifi
common
etiolog
agent
howev
benefici
effect
interferonb
treatment
ms
although
suggest
depend
mainli
immunomodul
might
lend
support
viral
involv
pathogenesi
human
herpesvirus
attract
interest
sinc
recurr
mode
infect
share
similar
relapsingremit
cours
ms
member
readili
detect
within
brain
sever
virus
may
induc
demyelin
within
central
nervou
system
human
host
well
anim
model
accumul
diagnost
epidemiolog
data
compat
role
herpesvirus
possibl
cofactor
rather
etiolog
agent
recent
studi
show
earli
neuron
damag
ms
patient
focu
attent
neurotrop
aherpesvirus
antivir
treatment
trial
safe
effect
drug
valaciclovir
offer
possibl
test
hypothes
concern
herpesvir
involv
ms
increas
number
safe
effect
antivir
substanc
avail
clinic
use
offer
new
therapeut
possibl
regard
chronic
diseas
suspect
viral
origin
shortli
definit
multipl
sclerosi
ms
clinic
entiti
form
chronic
multifoc
demyelin
diseas
central
nervou
system
cn
infecti
etiolog
suggest
mari
centuri
follow
sinc
despit
consider
diagnost
fig
increas
permeabl
bloodbrain
barrier
patholog
hallmark
multipl
sclerosi
supravit
dye
test
plaqu
anterior
horn
subependym
zone
lesion
increas
vascular
permeabl
illustr
broman
permeabl
cerebrospin
vessel
normal
patholog
condit
munksgaard
copenhagen
plate
iii
figur
effort
johnson
gilden
et
al
etiolog
agent
causal
treatment
ms
hitherto
identifi
among
virus
candid
almost
viru
famili
suggest
contributor
pathogenesi
ms
often
stimul
discoveri
new
viral
member
find
concern
known
virus
obtain
improv
diagnost
mean
yet
year
present
contradictori
data
viral
candid
disappear
oblivion
replac
new
candid
without
involv
decis
refut
strengthen
advanc
field
antivir
treatment
provid
new
opportun
test
hypothes
concern
viral
involv
ms
aim
current
review
rather
cover
immens
often
contradictori
literatur
associ
virus
diseas
provid
rational
clinic
trial
antivir
patient
ms
focus
possibl
contribut
pathogen
role
present
known
herpesvirus
progress
neurolog
deficit
ms
often
follow
relaps
remit
cours
exacerb
associ
expand
new
area
demyelin
cn
recoveri
remyelin
prinea
et
al
typic
demyelin
lesion
plaqu
found
brain
ms
patient
show
histolog
sign
activ
inflamm
typic
perivenular
often
symmetr
local
fog
central
patholog
plaqu
local
breakdown
bloodbrain
barrier
earli
develop
lesion
visual
supravit
dye
test
brain
autopsi
illustr
fig
magnet
reson
imag
mri
fig
laboratori
diagnost
criteria
poser
et
al
includ
presenc
patholog
igg
index
well
oligoclon
band
gamma
region
isoelectr
focus
csf
protein
indic
clonal
expans
bcell
intrathec
antibodi
product
mild
mononuclear
pleocytosi
often
found
csf
includ
clone
activ
tcell
target
myelinrel
autoantigen
myelin
basic
protein
mbp
possibl
due
molecular
mimicri
pathogen
herpesvirus
hafler
weiner
ota
et
al
wucherpfennig
stroming
henc
ms
regard
tcell
mediat
autoimmun
diseas
due
aberr
immun
regul
waksman
reynold
support
hypothesi
obtain
anim
model
reproduc
symptom
sign
demyelin
inject
myelin
activ
tcell
reactiv
substanc
wekerl
et
al
accord
theori
extens
reiter
autoinflammatori
demyelin
ultim
lead
chronic
phase
diseas
neuron
destruct
axon
damag
occur
rational
treatment
immunomodulatori
drug
steroid
interferon
deriv
hypothesi
bashir
whitak
expans
partli
conflict
concept
recent
investig
employ
new
techniqu
indic
onset
axon
lesion
may
earli
rather
late
event
ms
use
antibodi
amyloid
precursor
protein
marker
axon
destruct
express
protein
document
area
acut
inflamm
demyelin
well
border
zone
activ
chronic
lesion
brain
ms
patient
ferguson
et
al
anoth
autopsi
studi
abund
axon
transect
document
activ
lesion
trapp
et
al
furthermor
solubl
marker
neuron
damag
neurofila
protein
detect
csf
earli
relapsingremit
phase
diseas
highest
concentr
protein
found
onset
exacerb
lyck
et
al
addit
magnet
reson
spectroscop
imag
use
neuron
marker
nacetylaspart
suggest
widespread
axon
damag
also
area
outsid
visibl
plaqu
narayanan
et
al
earlier
report
clinic
data
regard
success
neurolog
symptom
relapsingremit
ms
indic
restrict
dissemin
symptom
axon
connect
area
brain
andersen
taken
togeth
find
suggest
axon
damag
occur
alreadi
initi
phase
neurolog
deterior
mayb
even
preced
andor
extend
beyond
inflammatori
lesion
may
drive
forc
pathogenesi
diseas
consequ
earli
therapeut
intervent
aim
neuron
protect
advoc
ferguson
et
al
trapp
et
al
epidemiolog
data
compat
involv
infect
environment
factor
pathogenesi
ms
geograph
uneven
distribut
diseas
form
sometim
debat
northsouth
gradient
declin
incid
opposit
observ
report
southern
hemispher
togeth
migrat
data
suggest
environment
exposur
unidentifi
risk
factor
adolesc
decis
import
detel
et
al
kurtzk
factor
might
transmiss
agent
support
longterm
epidemiolog
studi
faro
island
suggest
exist
four
success
declin
wave
ms
incid
onward
could
explain
infecti
agent
introduc
popul
second
world
war
slowli
vanish
kurtzk
addit
sever
report
nonfamili
cluster
ms
case
publish
data
argu
exist
specif
msrelat
pathogen
adolesc
vulner
period
prysephillip
howev
epidemiolog
diagnost
evid
postul
agent
viru
although
csf
abnorm
found
ms
patient
form
persist
intrathec
igg
product
determin
elev
iggindex
presenc
oligoclon
band
promin
chronic
viral
infect
hiv
andersson
et
al
follow
acut
herp
simplex
enceph
vandvik
et
al
similar
chang
may
also
evok
chronic
bacteri
cn
infect
neuroborreliosi
kaiser
attempt
made
identifi
put
msagent
antigen
overlay
oligoclon
band
intrathec
respons
ms
seem
broad
specif
also
found
case
chronic
neuroborreliosi
kaiser
furthermor
numer
studi
shown
elev
igg
csf
titer
plethora
virus
includ
morbilli
herpesvirus
adam
imagawa
norrbi
salmi
et
al
find
propos
repres
immunolog
reactiv
term
mstrait
poser
import
genet
factor
could
deduc
high
incid
ms
ethnic
group
emphas
concord
rate
diseas
monozygot
dizygot
twin
increas
risk
develop
diseas
found
sibl
ms
patient
eber
et
al
eber
et
al
extens
effort
made
identifi
respons
gene
inconclus
result
although
candid
gene
relat
immun
function
hillert
myelin
tienari
et
al
identifi
recent
studi
fail
defin
singl
strong
locu
sawcer
et
al
date
overrepresent
hla
class
ii
molecul
haplotyp
ms
patient
remain
import
genet
basi
suscept
diseas
hain
et
al
sinc
specif
genet
alter
found
normal
haplotyp
might
contribut
ms
trait
hillert
search
continu
studi
possibl
genet
linkag
multipl
loci
sawcer
et
al
hogancamp
et
al
detail
analys
repeat
sequenc
promot
region
mbp
gene
finnish
popul
tienari
et
al
conclus
genet
data
collect
hitherto
compat
ms
trait
might
confer
genet
suscept
uniqu
common
infecti
agent
mayb
alter
immun
respons
includ
antigen
present
andor
affect
target
tissu
myelin
role
environment
factor
trigger
ms
relaps
best
exemplifi
epidemiolog
studi
upper
respiratori
tract
infect
urti
four
differ
group
independ
document
risk
clinic
exacerb
week
follow
onset
infect
sibley
et
al
andersen
et
al
panitch
edward
et
al
possibl
mechan
mediat
increas
diseas
activ
might
virusinduc
secret
interferong
cytokin
stimul
sever
urtiassoci
virus
shown
induc
rather
prevent
ms
attack
clinic
trial
panitch
et
al
one
studi
urti
epidemiolog
evalu
interferonb
treatment
urtirel
attack
rate
lower
despit
fact
urti
prevent
panitch
author
suggest
interferonb
might
modul
immun
respons
viral
infect
panitch
anoth
possibl
could
treatment
restrict
viral
dissemin
cn
howev
despit
suggest
adenoviru
involv
serolog
find
one
studi
andersen
et
al
sever
differ
virus
anoth
trial
edward
et
al
studi
includ
pcrbase
diagnosi
necessari
defin
virus
may
respons
urtirel
bout
common
urti
involv
roughli
estim
cite
studi
relaps
ms
remain
attack
induc
among
sever
attract
candid
agent
human
herpesvirus
show
follow
characterist
featur
special
interest
context
ms
pathogen
primari
infect
childhood
adolesc
lifelong
infect
may
follow
latentrecurr
cours
similar
relapsingremit
charact
ms
herpesvirus
caus
persist
infect
cn
least
form
dna
baring
pisani
sander
et
al
herpesvirus
aherpesvirus
axon
transport
within
neuron
kristensson
et
al
lyck
et
al
wroblewska
et
al
sever
herpesvirus
induc
demyelin
diseas
cn
vahln
et
al
bray
et
al
carrigan
et
al
kleinschmidtdemast
et
al
spite
resembl
condit
diagnost
data
current
suffici
strong
valid
argument
herpesvirus
like
involv
pathogenesi
ms
suggest
virus
paraor
orthomyxovirus
papovavirus
coronavirus
weiner
et
al
mcdermott
et
al
burk
et
al
addit
easili
identifi
modern
diagnost
procedur
herpesvirus
one
clear
advantag
clinic
ms
research
contribut
diseas
activ
might
test
longterm
antivir
suppress
lyck
et
al
result
review
previou
recent
studi
present
evid
involv
differ
herpesvirus
ms
eight
human
herpesvirus
identifi
three
classifi
aherpesvirus
herp
simplex
viru
hsv
type
varicellazosterviru
vzv
three
bherpesvirus
cytomegaloviru
cmv
human
herpesviru
two
gherpesvirus
epsteinbarr
viru
ebv
human
herpesviru
also
descript
known
kaposi
sarcomaassoci
herpesviru
tabl
clinic
spectrum
cn
diseas
associ
demyelin
antivir
treatment
possibl
shown
eight
human
herpesvirus
case
report
publish
regard
iceland
woman
die
pneumonia
suffer
ms
nearli
three
decad
midbrain
hsv
isol
autopsi
strain
design
ms
strain
later
serolog
type
gudnadottir
et
al
ms
strain
wide
use
experiment
system
demyelin
martin
nathanson
henken
et
al
compar
virul
studi
strain
scarc
recent
note
isol
contrast
strain
unabl
suppress
delay
type
hypersensit
eye
infect
akiba
et
al
genotyp
correl
phenotyp
properti
present
quarter
centuri
later
isol
strain
design
ban
csf
previous
healthi
woman
show
symptom
doubl
vision
dizzi
sensori
defect
et
al
follow
year
develop
clinic
definit
relapsingremit
ms
accord
criteria
poser
et
al
judg
ban
strain
retriev
first
clinic
attack
ms
later
attempt
viru
isol
patient
repeatedli
neg
enter
secondari
progress
phase
ban
strain
differ
clinic
isol
lowli
neurovirul
vivo
model
et
al
strain
replic
lower
titer
cell
cultur
genotyp
character
strain
ongo
intrathec
antibodi
hsv
find
describ
ms
patient
et
al
sandbergwollheim
et
al
detect
csf
first
third
second
attack
patient
motiv
find
isol
perform
extens
search
pcr
dna
hsv
herpesvirus
csf
serum
sampl
ms
patient
howev
although
studi
includ
mani
sampl
drawn
acut
attack
result
neg
martin
et
al
mous
model
demyelin
shown
exhibit
interest
featur
resembl
ms
vahln
et
al
studi
trigemin
ganglion
infect
mice
myelin
sheet
trigemin
nerv
root
entri
zone
belong
cn
sever
injur
viru
myelin
pn
remain
intact
kristensson
et
al
kristensson
et
al
demyelin
pronounc
week
appear
involv
cytocid
effect
oligodendrocyt
infect
kristensson
et
al
kristensson
et
al
furthermor
demyelin
process
might
follow
relapsingremit
cours
sinc
area
brain
stem
show
acut
focal
demyelin
well
remyelin
also
latent
phase
kristensson
et
al
mous
straindepend
suscept
multifoc
demyelin
demonstr
kastrukoff
et
al
group
later
report
immunosuppress
increas
viral
spread
brain
prevent
develop
demyelin
mous
model
kastrukoff
et
al
vzv
one
ubiquit
human
virus
parallel
ms
common
temper
zone
except
north
american
hutterit
popul
whose
peopl
live
rel
isol
rest
societi
less
clinic
varicella
well
zoster
popul
ms
less
common
surround
popul
ross
although
find
could
mere
indic
popul
protect
sever
infecti
agent
combin
epidemiolog
pictur
inspir
uncontrol
trial
vzv
vaccin
ms
patient
ross
et
al
support
possibl
role
vzv
ms
pathogenesi
might
drawn
presenc
intrathec
antibodi
vzv
ms
sindic
et
al
increas
antibodi
chronic
progress
form
diseas
schadlich
et
al
addit
whitematt
lesion
indic
myelin
damag
promin
find
vzv
enceph
kleinschmidtdemast
et
al
focal
demyelin
brainstem
describ
trigemin
zoster
aid
patient
rosenblum
anim
model
viru
distribut
axon
well
hematogen
mode
spread
vzv
suggest
wroblewska
et
al
human
aherpesvirus
least
vzv
report
present
brain
ms
patient
well
control
subject
baring
pisani
sander
et
al
share
capac
induc
demyelin
may
relaps
man
anim
model
kristensson
et
al
martin
nathanson
vahln
et
al
kleinschmidtdemast
et
al
furthermor
virus
reactiv
cn
without
affect
peripheri
mayo
booss
et
al
gilden
et
al
echevarria
et
al
addit
csf
find
show
similar
ms
human
aherpesviru
cn
infect
besid
specif
antibodi
respons
vandvik
et
al
sandbergwollheim
et
al
possibl
presenc
hsvantigen
coyl
kamei
et
al
ms
aherpesviru
cn
infect
predomin
respons
suggest
cytokin
profil
includ
rise
ifng
solubl
receptor
aureliu
et
al
sivieri
et
al
facial
palsi
condit
routin
affect
function
relat
neighbour
cranial
nerv
elev
level
mbp
well
increas
antibodi
titer
protein
regularli
detect
csf
therefor
diseas
might
regard
model
diseas
focal
demyelin
brainstem
vahln
et
al
old
suggest
hsv
etiolog
facial
palsi
mcgormick
recent
support
report
endoneur
fluid
drawn
facial
nerv
contain
dna
patient
bell
palsi
vzv
dna
ramsayhunt
case
murakami
et
al
anoth
studi
patient
bell
palsi
serolog
confirm
herpesviru
etiolog
csf
sampl
pcrneg
herpesviru
dna
exemplifi
diagnost
difficulti
limit
cn
affect
caus
virus
larsson
et
al
studi
elev
level
tnfa
found
cytokin
associ
demyelin
earlier
shown
occur
rais
csf
level
ms
patient
selmaj
rain
sharief
hentg
challeng
hypothesi
hsv
involv
treatment
trial
combin
aciclovir
steroid
bell
palsi
suggest
medic
might
prevent
longterm
sequela
subset
patient
adour
et
al
extens
neurolog
involv
cranial
nerv
document
studi
indic
brainstem
involv
rather
limit
affect
mere
one
peripher
nerv
adour
et
al
mention
relaps
ms
might
induc
differ
trigger
agent
among
could
aherpesvirus
addit
urtirel
virus
microbi
agent
suggest
support
fact
intrathec
igg
respons
direct
differ
viral
antigen
separ
relaps
sandbergwollheim
et
al
hypothesi
aherpesvirus
might
caus
relaps
ms
could
challeng
antivir
trial
may
reason
even
relaps
ms
relat
recurr
aherpesvirus
antivir
treatment
suppress
virus
might
reduc
number
attack
although
famciclovir
report
superior
valaciclovir
reduc
amount
latent
cn
mice
model
thackray
field
antivir
drug
hitherto
best
document
effect
human
aherpesviru
infect
cn
aciclovir
tabl
herp
simplex
enceph
two
separ
studi
shown
iv
infus
drug
benefici
outcom
littl
toxic
superior
vidarabin
earlier
shown
effect
also
neonat
enceph
ldenberg
et
al
whitley
et
al
whitley
provid
adequ
csf
concentr
reach
involv
aherpesvirus
ms
could
therefor
test
trial
use
aciclovir
see
bherpesvirus
rel
newli
discov
tlymphotrop
viru
attract
consider
interest
context
ms
pathogenesi
addit
caus
exanthema
subitum
found
cn
tropism
demonstr
associ
febril
seizur
meningoenceph
asano
et
al
kondo
et
al
suga
et
al
occasion
acut
demyelin
kamei
et
al
may
also
induc
mslike
multifoc
demyelin
encephalomyel
white
matter
lesion
carrigan
et
al
novoa
et
al
report
caus
agent
case
encephalopathi
mspatient
merelli
et
al
search
unknown
pathogen
represent
differenti
analysi
dna
dna
deriv
brain
mspatient
differ
control
dna
contain
extra
viral
sequenc
shown
belong
genom
challon
et
al
studi
show
control
brain
also
contain
dna
even
express
antigen
differ
found
form
virusrel
stain
nuclei
oligodendrocyt
exclus
observ
ms
patient
challon
et
al
group
found
increas
igm
igg
respons
ms
patient
pcrposit
dna
csf
serum
sampl
also
report
sola
et
al
liedtk
et
al
soldan
et
al
howev
work
laboratori
other
fail
detect
dna
signific
number
serum
csf
sampl
ms
patient
addit
antibodi
titer
found
similar
healthi
control
martin
et
al
nielsen
et
al
fillet
et
al
furthermor
recent
studi
lymphocyt
stimul
indic
compar
healthi
individu
found
stimul
antigen
type
b
ms
patient
relapsingremit
phase
enbom
person
commun
studi
includ
anim
model
need
clarifi
role
ms
mere
exist
herpesviru
combin
properti
neurotrop
tcell
lymphotrop
infecti
phase
intrigu
littl
known
regard
neuropathogen
close
relat
viru
recent
detect
pcr
csf
child
epilept
syndrom
portolani
et
al
associ
demyelin
diseas
includ
ms
present
data
regard
occurr
import
primari
cmv
infect
reactiv
ms
patient
although
viru
may
present
normal
brain
sander
et
al
frequent
suggest
one
agent
induc
demyelin
peripher
nervou
system
form
syndrom
schmitz
ender
liedtk
et
al
case
cmvassoci
cn
demyelin
includ
transvers
myeliti
baig
khan
cerebr
white
matter
lesion
moskowitz
et
al
monno
et
al
howev
rare
occur
nonimmunocompromis
host
regard
therapeut
intervent
cn
infect
induc
bherpesvirus
combin
ganciclovir
foscarnet
attempt
cmv
due
low
efficaci
singl
drug
treatment
cinqu
et
al
rieux
et
al
earlier
studi
ic
valu
sever
clinic
isol
determin
replic
human
peripher
blood
monocyt
aciclovir
rang
mm
ganciclovir
rang
mm
foscarnet
rang
mgml
indic
therapeut
potenti
two
latter
antivir
system
infect
viru
agut
et
al
howev
except
cmv
retin
ganciclovir
foscarnet
cidofovir
benefici
effect
whitley
et
al
control
trial
hitherto
report
bherpesvirusinduc
cn
infect
tabl
even
form
infect
sever
find
justifi
attent
role
ebv
infect
demyelin
diseas
ms
patient
histori
mononucleosi
common
control
operskalski
et
al
cohort
mononucleosi
patient
ms
case
overrepres
lindberg
et
al
anoth
studi
histori
mononucleosi
younger
age
especi
associ
higher
risk
develop
ms
martyn
et
al
whether
find
could
directli
relat
ebv
infect
relat
immun
respons
mere
indic
ms
case
gener
rel
shield
viral
infect
earli
year
bachmann
kesselr
remain
undecid
still
neurolog
complic
occur
primari
ebv
infect
relaps
progress
deficit
link
demyelin
might
develop
bray
et
al
whether
process
possibl
influenc
antivir
treatment
unknown
sinc
control
antivir
trial
ebvinduc
cn
diseas
perform
search
herpesvir
dna
ms
brain
ebv
rel
uncommon
find
sander
et
al
ebv
rna
indic
activ
infect
detect
plaqu
hilton
et
al
hand
serolog
studi
repeatedli
shown
higher
preval
higher
titer
antibodi
ebv
ms
patient
compar
control
larsen
et
al
sumaya
et
al
myhr
et
al
possibl
address
question
regard
ebv
demyelin
develop
anim
model
yet
exploit
concern
latest
discov
member
human
gherpesvirus
strongli
link
kaposi
sarcoma
bodi
caviti
lymphoma
data
seropreval
conflict
evid
lower
herpesvirus
suggest
restrict
infect
gener
popul
regamey
et
al
although
associ
case
enceph
characterist
swell
endoteli
cell
said
et
al
demyelin
associ
viru
hitherto
report
unconfirm
report
dna
sequenc
detect
brain
ms
patient
well
brain
control
merelli
et
al
anim
virus
could
constitut
geograph
confin
environment
factor
therefor
repeatedli
associ
etiolog
ms
herpesviru
famili
except
avian
glike
herpesviru
marek
diseas
viru
mdv
interest
virolog
point
view
sinc
although
lymphotrop
herpesviru
share
neurotrop
properti
aherpesvirus
caus
outbreak
poultri
transient
paralysi
show
similar
pepos
et
al
parker
schierman
furthermor
transient
paralysi
recess
genet
trait
possibl
induc
antibodi
respons
parker
schierman
context
notabl
human
igg
antibodi
ebv
crossreact
mdv
antigen
macgregor
latiwonk
possibl
contribut
factor
unusu
southerli
cluster
ms
key
west
florida
popul
suggest
highli
expos
mdv
virus
migrat
wild
seabird
mcstreet
et
al
diagnost
epidemiolog
util
address
question
avian
herpesviru
mspopul
southern
florida
larg
studi
sampl
ms
patient
live
northern
germani
fail
detect
mdv
dna
quantit
pcr
peripher
leukocyt
hennig
et
al
line
research
investig
possibl
human
suscept
ancestr
herpesvirus
sinc
sever
epidemiolog
studi
suggest
ms
patient
expos
bird
pet
match
control
operskalski
et
al
cook
et
al
role
avian
anim
herpesvirus
diseas
warrant
investig
famili
retrovirus
particularli
htlvilik
oncovirus
sinc
long
implic
pathogenesi
ms
koprowski
et
al
later
suggest
put
forward
dual
infect
ebv
human
retroviru
might
event
import
ms
haahr
et
al
establish
blymphoblastoid
cell
line
ms
patient
simultan
express
ebv
retroviruslik
particl
found
munch
et
al
find
could
repeat
patient
howev
uniqu
ms
anoth
approach
pcr
amplif
peripher
blood
mononuclear
cell
use
longitudin
studi
presenc
herpesvir
retrovir
sequenc
acut
attack
relapsingremit
ms
ebvdna
earli
find
attack
often
follow
amplif
htlvlike
sequenc
ferrant
et
al
whether
find
possibl
transactiv
occur
also
cn
unknown
sinc
csf
sampl
includ
studi
hitherto
best
character
retroviru
associ
ms
deriv
ebvinfect
bcell
well
choroid
plexu
cell
ms
patient
perron
et
al
viru
design
multipl
sclerosi
associ
retroviru
msrv
close
relat
genet
distinct
known
virus
oncoviru
genu
form
extracellular
viru
particl
cultur
bcell
specif
rna
amplifi
csf
peripher
blood
cell
ms
patient
control
includ
case
enceph
myeliti
recent
express
cytotox
factor
specif
glial
cell
includ
oligodendrocyt
detect
supernat
msrvcontain
peripher
blood
cell
well
csf
drawn
ms
patient
menard
et
al
remain
decid
find
activ
retroviru
acut
relaps
ms
bear
etiolog
diseas
repres
interest
epiphenomen
relat
intrathec
immun
activ
oblig
constitu
condit
perron
et
al
progress
character
agent
may
provid
tool
use
diagnost
epidemiolog
studi
ms
may
shed
light
process
relat
immun
activ
within
cn
furthermor
relationship
msrelat
retrovirus
herpesvirus
need
clarif
exampl
whether
may
transactiv
vivo
shown
vitro
msrv
perron
et
al
simultan
detect
mere
coincident
recent
discoveri
retrovir
insert
natur
strain
avian
herpesviru
suggest
cooper
two
viru
famili
might
intim
endoh
et
al
great
effort
made
year
clarifi
pathogenesi
ms
work
profoundli
increas
understand
intrathec
immun
respons
includ
autoimmun
attack
myelinrel
protein
gene
involv
suscept
demyelin
process
well
cn
immun
cell
infect
plethora
virus
part
natur
lifecycl
consider
incongru
current
comprehens
ms
pathogenesi
despit
multitud
data
accumul
may
specul
addit
genet
trait
known
pathogen
possibl
act
cofactor
key
environment
factor
probabl
transmiss
remain
identifi
search
agent
limit
even
virus
like
pathogen
exist
combin
effort
research
commun
util
power
tool
molecular
biolog
eventu
find
miss
piec
await
discoveri
therapeut
progress
ms
continu
numer
clinic
trial
immunopharmacolog
therapi
perform
ms
patient
two
substanc
shown
clear
benefici
effect
interferonb
ifnb
glatiram
acet
bashir
whitak
recombin
ifnb
produc
two
form
glycosyl
contain
natur
aa
sequenc
nonglycosyl
carri
one
aa
delet
addit
point
mutat
show
clinic
effect
form
reduc
relaps
rate
reduct
mr
lesion
ifnb
multipl
sclerosi
studi
group
pati
et
al
rudick
et
al
former
variant
effect
vitro
antivir
assay
runkel
et
al
report
slow
progress
neurolog
disabl
rudick
et
al
although
mechan
action
clarifi
recent
report
effect
cytokin
express
patient
treat
lend
support
immunomodulatori
effect
direct
toward
respons
ie
upregul
interleukin
downregul
ifng
context
possibl
direct
antivir
effect
contribut
benefici
outcom
ifn
treatment
ms
patient
seldom
refer
deserv
mention
anim
experiment
system
ifn
show
broad
antivir
effect
sever
rna
dna
virus
includ
hsv
pinto
et
al
cell
cultur
direct
antivir
effect
hsv
especi
low
multipl
infect
shown
ifna
b
well
g
taylor
et
al
synergist
antihsv
effect
ifn
nucleosid
analogu
aciclovir
report
cell
cultur
system
includ
human
neural
cell
line
vari
origin
hanada
et
al
naito
et
al
howev
control
trial
human
ifn
singl
treatment
combin
nucleosid
analogu
hitherto
perform
herpesvirusinduc
cn
infect
unknown
dose
ifnb
use
ms
trial
result
concentr
abl
inhibit
replic
prevent
reactiv
herpesvirus
apart
interferonb
substanc
establish
benefit
relapsingremit
ms
glatiram
acet
copolym
four
amino
acid
alanin
lysin
glutam
acid
tyrosin
prepar
resembl
mbp
teitelbaum
et
al
johnson
bashir
whitak
patient
experienc
fewer
relaps
compar
control
higher
number
patient
show
neurolog
improv
treatment
group
johnson
addit
small
studi
evalu
serial
magnet
reson
imag
shown
reduct
new
lesion
compar
pretreat
period
mancardi
et
al
although
mechan
action
clarifi
cytokin
secret
mous
tcell
line
stimul
glatiram
acet
suggest
preferenti
respons
induc
crossreact
mbp
suppress
experiment
allerg
enceph
aharoni
et
al
observ
valid
also
mspatient
treat
substanc
current
known
addit
possibl
direct
antivir
mechan
contribut
benefici
effect
interferonb
antivir
compound
hitherto
investig
control
trial
ms
patient
aciclovir
lyck
et
al
aim
studi
test
hypothesi
hsv
involv
ms
rational
choic
aciclovir
document
effect
cn
infect
caus
viru
tabl
lack
toxic
studi
period
patient
relaps
remit
diseas
oral
treat
mg
aciclovir
tid
receiv
placebo
doubleblind
fashion
total
exacerb
encount
aciclovir
group
versu
placebo
group
fewer
relaps
aciclovir
recipi
p
subgroup
analysi
placebo
aciclovir
recipi
follow
year
initi
treatment
aciclovir
recipi
experienc
decrement
annual
exacerb
increas
annual
exacerb
record
placebo
group
lyck
et
al
convinc
sign
reduc
neurolog
deterior
aciclovir
group
note
pharmacokinet
studi
serumcsf
concentr
aciclovir
reach
steadi
state
dosag
subpopul
ms
patient
mean
serum
peak
trough
level
mm
respect
csf
mean
aciclovir
concentr
mm
valu
slightli
affect
fluctuat
assay
serum
sampl
lyck
et
al
thu
mean
penetr
rate
csf
aim
aherpesviru
replic
cn
assum
roughli
equal
distribut
csf
cn
tissu
biron
et
al
comparison
ic
valu
aciclovir
differ
herpesvirus
elion
fletcher
bean
csf
concentr
reach
suggest
suppress
herpesvirus
might
achiev
dosag
use
trial
addit
serum
concentr
judg
adequ
inhibit
also
vzv
replic
lyck
et
al
rel
insensit
band
gherpesvirus
vitro
would
exclud
possibl
effect
vivo
titer
serum
igg
antibodi
differ
herpesvirus
determin
preand
posttreat
signific
reduct
titer
found
aciclovir
recipi
placebo
group
titer
vzv
cmv
ebv
remain
constant
lyck
et
al
indic
achiev
suppress
hsv
nine
placebo
recipi
experienc
oral
lesion
studi
period
compar
one
aciclovir
recipi
lyck
et
al
given
opportun
improv
distribut
aciclovir
cn
increas
plasma
level
reach
prodrug
valaciclovir
beutner
new
investig
use
substanc
initi
ongo
placebocontrol
bicent
trial
evalu
patient
aarhu
denmark
teborg
sweden
effect
continu
valaciclovir
treatment
month
evalu
serial
mri
investig
oral
dose
select
g
tid
preliminari
result
pharmacokinet
studi
subject
given
ident
dose
indic
steadyst
csf
concentr
aciclovir
approxim
three
time
higher
level
reach
aciclovir
trial
lyck
et
al
lyck
person
commun
addit
suppress
possibl
effect
replic
vzv
also
within
cn
might
achiev
present
studi
regard
possibl
toxic
chosen
dosag
gday
g
bid
valaciclovir
found
safe
trial
shortterm
treatment
recurr
genit
herp
longterm
treatment
gday
aim
cmv
suppress
sever
ill
hiv
patient
toxic
patient
tyre
et
al
feinberg
et
al
although
chosen
dosag
current
trial
ms
expect
harm
patient
toxic
might
creat
upper
limit
attempt
util
valaciclovir
suppress
band
gherpesvirus
within
cn
cours
ms
possibl
problem
antivir
resist
longterm
treatment
address
surveil
aciclovir
sensit
hsv
vzv
strain
isol
studi
despit
consider
diagnost
effort
viral
agent
respons
etiolog
ms
hitherto
identifi
circumstanti
evid
sever
line
investig
suggest
role
herpesvirus
cofactor
diseas
investig
possibl
associ
ms
attack
reactiv
aherpesvirus
motiv
recent
find
earli
neuron
involv
ms
pathogenesi
result
anim
model
hsvinduc
demyelin
recent
confirm
etiolog
connect
hsv
anoth
demyelin
condit
cn
ie
facial
palsi
diagnost
data
form
previous
report
cnsderiv
hsv
isol
hsv
specif
immun
respons
found
ms
patient
diagnost
shortcom
relat
inaccess
ms
lesion
normal
presenc
herpesvirus
brain
prompt
challeng
hypothesi
antivir
treatment
oral
aciclovir
possibl
benefici
effect
shown
reduct
number
attack
pilot
studi
motiv
ongo
trial
use
valaciclovir
order
achiev
enhanc
penetr
aciclovir
cn
allow
suppress
least
aherpesvirus
compart
follow
develop
antivir
improv
safeti
better
cn
penetr
current
avail
futur
studi
might
target
also
band
gherpesvirus
ebv
hematogen
spread
herpesvirus
achiev
suppress
viral
replic
might
monitor
quantit
pcr
white
blood
cell
addit
serolog
third
possibl
target
antivir
treatment
ms
patient
could
virus
caus
urti
rhinovirus
final
consider
recent
report
benefici
outcom
diseas
progress
ifnb
treatment
combin
effect
safe
antivir
therapi
immunomodulatoryantivir
regimen
proven
efficaci
might
suggest
futur
treatment
trial
ms
patient
